Skip to main content

Vertex Pharmaceuticals United States revenue

  • VRTX · Nasdaq
  • Pharmaceuticals
  • Biotechnology
  • S&P 500
$538.60−0.74%Close 13 Nov 2026

United States revenue at Vertex Pharmaceuticals came to $2.2B for the quarter to 30 Sep 2026, up 9.8% from a year earlier.

As Vertex Pharmaceuticals reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 3 Nov 2026.

By quarter

$1.6BDec 2023$1.5BMar 2024$1.6BJun 2024$1.7BSep 2024$1.8BDec 2024$1.7BMar 2025$1.8BJun 2025$2.0BSep 2025$2.1BDec 2025$1.8BMar 2026$2.1BJun 2026$2.2BSep 2026
Vertex Pharmaceuticals United States revenue, every reported period
Period endingUnited States revenueChange on a yearFiled
30 Sep 2026$2.2Bup 9.8%3 Nov 2026
30 Jun 2026$2.1Bup 11.3%4 Aug 2026
31 Mar 2026$1.8Bup 6.8%5 May 2026
31 Dec 2025$2.1Bup 12.2%13 Feb 2026
30 Sep 2025$2.0Bup 15.3%4 Nov 2025
30 Jun 2025$1.8Bup 14.5%5 Aug 2025
31 Mar 2025$1.7Bup 9.4%6 May 2025
31 Dec 2024$1.8Bup 16.7%13 Feb 2025
30 Sep 2024$1.7Bup 10.2%5 Nov 2024
30 Jun 2024$1.6Bup 7.1%2 Aug 2024
31 Mar 2024$1.5Bup 8.3%7 May 2024
31 Dec 2023$1.6Bup 7.8%15 Feb 2024
30 Sep 2023$1.6Bup 6.8%7 Nov 2023
30 Jun 2023$1.5Bup 6.6%2 Aug 2023
31 Mar 2023$1.4Bup 2.6%2 May 2023
31 Dec 2022$1.5B—10 Feb 2023
30 Sep 2022$1.5Bup 5.3%28 Oct 2022
30 Jun 2022$1.4Bup 12.6%5 Aug 2022
31 Mar 2022$1.4Bup 9.2%6 May 2022
30 Sep 2021$1.4Bup 13.1%3 Nov 2021
30 Jun 2021$1.3Bup 3.8%30 Jul 2021
31 Mar 2021$1.3Bup 5.5%30 Apr 2021
31 Dec 2020$1.2Bup 19.6%11 Feb 2021
30 Sep 2020$1.2Bup 72.1%30 Oct 2020
30 Jun 2020$1.2Bup 72.7%31 Jul 2020
31 Mar 2020$1.2Bup 85.2%1 May 2020
31 Dec 2019$1.0Bup 49.2%13 Feb 2020
30 Sep 2019$710.3Mup 14.5%31 Oct 2019
30 Jun 2019$700.6Mup 19.8%1 Aug 2019
31 Mar 2019$641.1Mup 32.8%1 May 2019
31 Dec 2018$677.1Mup 34.6%13 Feb 2019
30 Sep 2018$620.5Mup 36.4%25 Oct 2018
30 Jun 2018$584.8Mup 36.1%26 Jul 2018
31 Mar 2018$482.7Mdown 19.4%27 Apr 2018
31 Dec 2017$503.1M—15 Feb 2018
30 Sep 2017$454.7M—30 Oct 2017
30 Jun 2017$429.8M—28 Jul 2017
31 Mar 2017$599.1M—28 Apr 2017

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Vertex Pharmaceuticals: Product revenues, net revenue · TRIKAFTA/KAFTRIO revenue · ALYFTREK revenue · CASGEVY revenue · JOURNAVX revenue · Europe revenue · financial statements

Every KPI and segment of VRTX, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.